Gateway Investment Advisers LLC Decreases Position in Avantor, Inc. (NYSE:AVTR)

Gateway Investment Advisers LLC decreased its holdings in Avantor, Inc. (NYSE:AVTRGet Rating) by 0.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 162,375 shares of the company’s stock after selling 872 shares during the period. Gateway Investment Advisers LLC’s holdings in Avantor were worth $5,050,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also modified their holdings of AVTR. Bank of New Hampshire purchased a new position in Avantor in the first quarter worth approximately $25,000. Byrne Asset Management LLC acquired a new stake in shares of Avantor in the 4th quarter valued at $32,000. Standard Family Office LLC purchased a new stake in shares of Avantor during the 4th quarter worth $50,000. EverSource Wealth Advisors LLC acquired a new position in shares of Avantor during the fourth quarter worth $55,000. Finally, Capital Advisors Ltd. LLC increased its holdings in Avantor by 224.2% in the first quarter. Capital Advisors Ltd. LLC now owns 2,211 shares of the company’s stock valued at $75,000 after buying an additional 1,529 shares during the last quarter. Hedge funds and other institutional investors own 81.22% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on AVTR. KeyCorp decreased their price target on Avantor from $51.00 to $40.00 and set an “overweight” rating for the company in a report on Thursday, September 15th. UBS Group lowered their price target on Avantor to $42.00 in a report on Thursday, September 15th. Evercore ISI cut their price objective on shares of Avantor to $35.00 in a report on Tuesday, August 9th. Citigroup lowered their target price on shares of Avantor from $32.00 to $28.00 and set a “neutral” rating for the company in a report on Wednesday, September 14th. Finally, Cowen lowered shares of Avantor from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $39.00 to $28.00 in a research note on Wednesday, September 14th. Four investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to data from MarketBeat, Avantor currently has a consensus rating of “Moderate Buy” and a consensus target price of $33.43.

Avantor Stock Performance

Shares of AVTR stock opened at $20.95 on Friday. Avantor, Inc. has a 52-week low of $20.78 and a 52-week high of $44.37. The stock’s 50-day moving average price is $26.85 and its 200 day moving average price is $30.06. The company has a quick ratio of 1.05, a current ratio of 1.64 and a debt-to-equity ratio of 1.41. The stock has a market capitalization of $14.12 billion, a PE ratio of 22.53, a price-to-earnings-growth ratio of 1.91 and a beta of 1.34.

Avantor (NYSE:AVTRGet Rating) last released its earnings results on Thursday, July 28th. The company reported $0.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.01). Avantor had a net margin of 8.27% and a return on equity of 27.14%. The company had revenue of $1.91 billion during the quarter, compared to analyst estimates of $1.98 billion. During the same period in the previous year, the firm posted $0.35 EPS. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. As a group, equities research analysts forecast that Avantor, Inc. will post 1.45 EPS for the current year.

About Avantor

(Get Rating)

Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with's FREE daily email newsletter.